Ethical Compliance
AUROBINDO PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
1%
Debt
14%
Liquidity
13.9%
Revenue
Debt
Liquidity
1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Pharmaceuticals Products | ₹28,223.30 |
| Job Work Income | ₹481.20 |
| Government Incentive Schemes | ₹276.77 |
| Scrap Sales | ₹20.60 |
| other income | ₹268.09 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹289.29 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹289.29 |
| Total: | ₹289.29 |
| Total Revenue: | ₹29,559.25 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹289.29
₹29,559.25
= 1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
